These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 33326054)

  • 1. [Proliferative vitreoretinopathy process-To heal or not to heal].
    Grisanti S; Priglinger S; Hattenbach L
    Ophthalmologe; 2021 Jan; 118(1):10-17. PubMed ID: 33326054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Proliferative vitreoretinopathy--pathogenesis and therapy].
    Iandiev I; Bringmann A; Wiedemann P
    Klin Monbl Augenheilkd; 2010 Mar; 227(3):168-74. PubMed ID: 20234978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Proliferative vitreoretinopathy (PVR) surgery: Scar Wars : Five steps to successful treatment of PVR detachment].
    Priglinger SG; Siedlecki J; Hattenbach LO; Grisanti S
    Ophthalmologe; 2021 Jan; 118(1):18-23. PubMed ID: 33346893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Proliferative Vitreoretinopathy].
    Wiedemann P; Bringmann A
    Klin Monbl Augenheilkd; 2016 Sep; 233(9):1012-5. PubMed ID: 27479581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferative vitreoretinopathy--is it anything more than wound healing at the wrong place?
    Weller M; Wiedemann P; Heimann K
    Int Ophthalmol; 1990 Mar; 14(2):105-17. PubMed ID: 2187005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferative vitreoretinopathy: an overview.
    Pastor JC
    Surv Ophthalmol; 1998; 43(1):3-18. PubMed ID: 9716190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and risk factors for proliferative vitreoretinopathy in eyes with rhegmatogenous retinal detachment but no previous vitreoretinal surgery.
    Tseng W; Cortez RT; Ramirez G; Stinnett S; Jaffe GJ
    Am J Ophthalmol; 2004 Jun; 137(6):1105-15. PubMed ID: 15183797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study of matrix metalloproteinases in proliferative vitreoretinopathy.
    Kon CH; Occleston NL; Charteris D; Daniels J; Aylward GW; Khaw PT
    Invest Ophthalmol Vis Sci; 1998 Jul; 39(8):1524-9. PubMed ID: 9660504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Laser flare photometry for identification of high-risk patients for proliferative vitreoretinopathy].
    Schaub F; Fauser S; Kirchhof B; Witte A; Hörster R
    Ophthalmologe; 2018 Dec; 115(12):1079-1083. PubMed ID: 30151741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patomechanisms in proliferative vitreoretinopathy.
    Kaczmarek R; Misiuk-Hojło M
    Klin Oczna; 2011; 113(1-3):64-7. PubMed ID: 21853955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinal Detachment and Proliferative Vitreoretinopathy.
    Kwon OW; Song JH; Roh MI
    Dev Ophthalmol; 2016; 55():154-62. PubMed ID: 26501375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Retinal detachment with anterior proliferative vitreoretinopathy and its surgical treatment].
    Liu W; Wang J; Chen H
    Zhonghua Yan Ke Za Zhi; 2000 Sep; 36(5):351-4. PubMed ID: 11853627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferative vitreoretinopathy-developments in adjunctive treatment and retinal pathology.
    Charteris DG; Sethi CS; Lewis GP; Fisher SK
    Eye (Lond); 2002 Jul; 16(4):369-74. PubMed ID: 12101443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamponade in surgery for retinal detachment associated with proliferative vitreoretinopathy.
    Schwartz SG; Flynn HW; Lee WH; Wang X
    Cochrane Database Syst Rev; 2014 Feb; 2(2):CD006126. PubMed ID: 24532038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Proteome of Preretinal Tissue in Proliferative Vitreoretinopathy.
    Miller CG; Henderson M; Mantopoulos D; Leskov I; Greco T; Schwarzbauer JE; Prenner JL
    Ophthalmic Surg Lasers Imaging Retina; 2021 Jul; 52(S1):S5-S12. PubMed ID: 34310239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Proliferative vitreoretinopathy (PVR) minimal: same, same but different. Characteristics and surgical treatment of PVR-associated macular pucker].
    Hattenbach LO; Grisanti S; Priglinger SG; Chronopoulos A
    Ophthalmologe; 2021 Jan; 118(1):24-29. PubMed ID: 33336260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraocular beta-radiation for proliferative vitreo-retinopathy.
    Shah P; Kon C; Rassam S
    Med Hypotheses; 2014 Apr; 82(4):421-3. PubMed ID: 24529642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of gene expression profile of epiretinal membranes obtained from eyes with proliferative vitreoretinopathy to that of secondary epiretinal membranes.
    Asato R; Yoshida S; Ogura A; Nakama T; Ishikawa K; Nakao S; Sassa Y; Enaida H; Oshima Y; Ikeo K; Gojobori T; Kono T; Ishibashi T
    PLoS One; 2013; 8(1):e54191. PubMed ID: 23372684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of thrombin in proliferative vitreoretinopathy.
    Bastiaans J; van Meurs JC; Mulder VC; Nagtzaam NM; Smits-te Nijenhuis M; Dufour-van den Goorbergh DC; van Hagen PM; Hooijkaas H; Dik WA
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(7):4659-66. PubMed ID: 25015355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
    Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N
    Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.